Cosmos Health Inc. (COSM) - 8-K Summary
Business Context and Reporting Period
Cosmos Health Inc., a Nevada corporation trading on the Nasdaq Capital Market, filed this Current Report on Form 8-K on April 15, 2026. The filing announces the release of financial results for the fiscal year ended December 31, 2025, via a press release attached as Exhibit 99.1.
Key Financial Metrics
Based on the press release title included in the filing, the following metrics were reported for the fiscal year ended December 31, 2025:
- Revenue: $65.3 million (All-time record).
- Gross Profit: $7.9 million.
- Gross Margin: Expanded by 418 basis points.
- Adjusted EPS: Improved by 82%.
- Cash Position: $3.5 million (Representing a 10x increase).
The filing text does not provide specific values for net profit, operating cash flow, total debt, or liquidity ratios beyond the cash position mentioned above.
Material Changes vs. Prior Period
- Revenue Growth: Increased by 20% compared to the prior period.
- Gross Profit Growth: Surged by 83%.
- Liquidity: Cash position increased tenfold.
- Profitability: Adjusted earnings per share improved significantly by 82%.
Outlook, Risks, and Management Commentary
Management commentary indicates that record growth continued into 2026 across all core segments. The filing includes standard forward-looking statements regarding future results, transaction benefits, and timing, noting that actual results may differ materially due to risks and uncertainties. Specific risk factors are referenced in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and subsequent filings. The filing explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) for detailed breakdowns of revenue by segment and specific definitions of "Adjusted EPS."
- Review the audited financial statements in the Form 10-K for the fiscal year ended December 31, 2025, to confirm the $65.3M revenue and $7.9M gross profit figures.
- Examine the balance sheet in the 10-K to understand the composition of the $3.5M cash position and total debt levels.
- Assess the specific risk factors disclosed in the 2025 10-K that could impact the projected growth into 2026.